Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy
Abstract only
Saved in:
Published in | Journal of clinical oncology Vol. 36; no. 15_suppl; p. 6014 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2018
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!